Annual Cash & Cash Equivalents
$4.79 M
-$2.04 M-29.91%
December 31, 2023
Summary
- As of February 12, 2025, MTNB annual cash & cash equivalents is $4.79 million, with the most recent change of -$2.04 million (-29.91%) on December 31, 2023.
- During the last 3 years, MTNB annual cash & cash equivalents has fallen by -$7.65 million (-61.50%).
- MTNB annual cash & cash equivalents is now -78.41% below its all-time high of $22.17 million, reached on December 31, 2019.
Performance
MTNB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.29 M
+$6.08 M+144.19%
September 30, 2024
Summary
- As of February 12, 2025, MTNB quarterly cash and cash equivalents is $10.29 million, with the most recent change of +$6.08 million (+144.19%) on September 30, 2024.
- Over the past year, MTNB quarterly cash and cash equivalents has increased by +$3.89 million (+60.68%).
- MTNB quarterly cash and cash equivalents is now -73.88% below its all-time high of $39.41 million, reached on March 31, 2019.
Performance
MTNB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MTNB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.9% | +60.7% |
| 3 y3 years | -61.5% | +60.7% |
| 5 y5 years | -61.5% | +60.7% |
MTNB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.2% | at low | -51.0% | +861.3% |
| 5 y | 5-year | -78.4% | at low | -66.1% | +861.3% |
| alltime | all time | -78.4% | +84.8% | -73.9% | +1680.2% |
Matinas BioPharma Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.29 M(+144.2%) |
| Jun 2024 | - | $4.22 M(+293.7%) |
| Mar 2024 | - | $1.07 M(-77.6%) |
| Dec 2023 | $4.79 M(-29.9%) | $4.79 M(-25.3%) |
| Sep 2023 | - | $6.41 M(-34.2%) |
| Jun 2023 | - | $9.74 M(+69.8%) |
| Mar 2023 | - | $5.74 M(-16.0%) |
| Dec 2022 | $6.83 M(-67.5%) | $6.83 M(-38.9%) |
| Sep 2022 | - | $11.18 M(+7.5%) |
| Jun 2022 | - | $10.40 M(-46.2%) |
| Mar 2022 | - | $19.33 M(-8.1%) |
| Dec 2021 | $21.03 M(+69.2%) | $21.03 M(-15.6%) |
| Sep 2021 | - | $24.92 M(-17.9%) |
| Jun 2021 | - | $30.35 M(+29.8%) |
| Mar 2021 | - | $23.38 M(+88.1%) |
| Dec 2020 | $12.43 M(-43.9%) | $12.43 M(+76.3%) |
| Sep 2020 | - | $7.05 M(-52.7%) |
| Jun 2020 | - | $14.90 M(+47.9%) |
| Mar 2020 | - | $10.08 M(-54.5%) |
| Dec 2019 | $22.17 M | $22.17 M(-32.1%) |
| Sep 2019 | - | $32.66 M(-11.3%) |
| Jun 2019 | - | $36.83 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $39.41 M(+216.6%) |
| Dec 2018 | $12.45 M(+70.4%) | $12.45 M(+87.7%) |
| Sep 2018 | - | $6.63 M(-25.5%) |
| Jun 2018 | - | $8.90 M(+108.8%) |
| Mar 2018 | - | $4.26 M(-41.7%) |
| Dec 2017 | $7.31 M(+78.0%) | $7.31 M(-18.8%) |
| Sep 2017 | - | $9.00 M(-20.1%) |
| Jun 2017 | - | $11.27 M(-28.9%) |
| Mar 2017 | - | $15.83 M(+285.7%) |
| Dec 2016 | $4.11 M(+27.2%) | $4.11 M(-34.0%) |
| Sep 2016 | - | $6.22 M(+975.5%) |
| Jun 2016 | - | $578.30 K(-65.4%) |
| Mar 2016 | - | $1.67 M(-48.1%) |
| Dec 2015 | $3.23 M(+24.6%) | $3.23 M(-26.0%) |
| Sep 2015 | - | $4.36 M(-34.0%) |
| Jun 2015 | - | $6.61 M(+43.1%) |
| Mar 2015 | - | $4.62 M(+78.2%) |
| Dec 2014 | $2.59 M(-76.1%) | $2.59 M(-48.3%) |
| Sep 2014 | - | $5.01 M(-24.7%) |
| Jun 2014 | - | $6.65 M(-22.3%) |
| Mar 2014 | - | $8.56 M(-21.1%) |
| Dec 2013 | $10.84 M | $10.84 M |
FAQ
- What is Matinas BioPharma Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual cash & cash equivalents year-on-year change?
- What is Matinas BioPharma Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly cash and cash equivalents year-on-year change?
What is Matinas BioPharma Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of MTNB is $4.79 M
What is the all time high annual cash & cash equivalents for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual cash & cash equivalents is $22.17 M
What is Matinas BioPharma Holdings annual cash & cash equivalents year-on-year change?
Over the past year, MTNB annual cash & cash equivalents has changed by -$2.04 M (-29.91%)
What is Matinas BioPharma Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MTNB is $10.29 M
What is the all time high quarterly cash and cash equivalents for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly cash and cash equivalents is $39.41 M
What is Matinas BioPharma Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, MTNB quarterly cash and cash equivalents has changed by +$3.89 M (+60.68%)